Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (DCalloTX)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Technische Universität Dresden.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Technische Universität Dresden
ClinicalTrials.gov Identifier:
NCT00450268
First received: March 21, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
  Purpose
We plan to investigate prospectively and simultaneously skin and blood DC subtypes, their donor/recipient origin and the correlation of DC reconstitution kinetics with treatment, clinical outcome and incidence of aGvHD in patients undergoing allogeneic hematopoietic stem cell transplantation.

Condition Intervention
Graft Versus Host Disease
Procedure: blood draw, skin shave biopsy

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Analysis of Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

Resource links provided by NLM:


Further study details as provided by Technische Universität Dresden:

Estimated Enrollment: 50
Study Start Date: January 2005
Estimated Study Completion Date: January 2010
Detailed Description:
Blood and skin DC reconstitution shall be investigated in patients affected by hematological diseases and receiving HLA-matched, mobilized peripheral blood stem cells from related or unrelated donors. We plan to simultaneously collect and process double biopsies, i.e. from graft versus host disease affected and non-lesional skin of patients at onset of acute graft versus host disease following allogeneic hematopoietic stem cell transplantation. Emigration assay, Chimerism analysis and immunohistochemistry will be performed.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient undergoing an allogeneic hematopoietic stem cell transplantation
  • Older than 18 years
  • WHO-Performance-Status 0 to3
  • Informed consent
  • Graft versus host disease of the skin

Exclusion Criteria:

  • Clotting parameters more than double of normal
  • Infection of the skin
  • Leucocytes < 1000/µl; Thrombocytes < 20 000/µl
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00450268

Locations
Germany
Universitätsklinik Carl Gustav Carus
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Investigators
Principal Investigator: Susanne Gretzinger, MD Universität Carl Gustav Carus Med Klinik I
  More Information

ClinicalTrials.gov Identifier: NCT00450268     History of Changes
Other Study ID Numbers: EK208122001 
Study First Received: March 21, 2007
Last Updated: March 21, 2007
Health Authority: Germany: Ethics Commission

Keywords provided by Technische Universität Dresden:
Graft versus host disease
Allogeneic hematpoietic stem cell transplantation

Additional relevant MeSH terms:
Graft vs Host Disease
Immune System Diseases

ClinicalTrials.gov processed this record on December 02, 2016